| ISIN | CH0364960242 |
|---|---|
| Valor Number | 36496024 |
| Bloomberg Global ID | |
| Fund Name | VF (CH) - Valiant Helvétique Balanced VA |
| Fund Provider |
Valiant Bank
Bern, Switzerland Phone: +41 31 320 91 11 Web: www.valiantbank.ch |
| Fund Provider | Valiant Bank |
| Representative in Switzerland |
Lombard Odier Asset Management (Switzerland) SA Bellevue (Geneva) Phone: +41 22 709 21 11 |
| Distributor(s) | Valiant Bank AG |
| Asset Class | Asset Allocation |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | |
| Peculiarities |
| Current Price * | 129.92 CHF | 18.12.2025 |
|---|---|---|
| Previous Price * | 129.39 CHF | 17.12.2025 |
| 52 Week High * | 129.92 CHF | 18.12.2025 |
| 52 Week Low * | 114.58 CHF | 09.04.2025 |
| NAV * | 129.92 CHF | 18.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 607,532,668 | |
| Unit/Share Assets *** | 255,003,360 | |
| Trading Information SIX | ||
| YTD Performance | +9.38% |
31.12.2024 - 18.12.2025
31.12.2024 18.12.2025 |
|---|---|---|
| 1 month | +2.04% |
18.11.2025 - 18.12.2025
18.11.2025 18.12.2025 |
| 3 months | +2.83% |
18.09.2025 - 18.12.2025
18.09.2025 18.12.2025 |
| 6 months | +5.29% |
18.06.2025 - 18.12.2025
18.06.2025 18.12.2025 |
| 1 year | +9.08% |
18.12.2024 - 18.12.2025
18.12.2024 18.12.2025 |
| 2 years | +16.17% |
18.12.2023 - 18.12.2025
18.12.2023 18.12.2025 |
| 3 years | +22.62% |
19.12.2022 - 18.12.2025
19.12.2022 18.12.2025 |
| 5 years | +17.34% |
18.12.2020 - 18.12.2025
18.12.2020 18.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Muzinich Enhancedyield S-T HCHF Acc H | 4.79% | |
|---|---|---|
| UBS Gold Index Fund hCHF I-A acc | 4.39% | |
| AXAWF Euro Credit Total Ret I Cap CHF H | 2.85% | |
| FvS Bond Opportunities CHF IT | 2.84% | |
| Capital Group GlbCorpBd (LUX) Zh-CHF | 2.83% | |
| Novartis AG Registered Shares | 2.50% | |
| UBS Siat | 2.45% | |
| Swiss Rock Emerg Eq/Aktien Schw C | 2.34% | |
| zCapital Swiss Dividend Fund ZA | 2.18% | |
| Roche Holding AG | 2.14% | |
| Last data update | 30.09.2025 | |
| TER *** | 1.26% |
|---|---|
| TER date *** | 31.10.2019 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.66% |
| Ongoing Charges *** | 1.28% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |